e-Drug3D

1143

cas 2152-34-3

CLASS

NERVOUS SYSTEM
CNS STIMULANT
ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
DOPAMIMETIC DRUG

ROUTE (list)

ORAL

PK parameters

Tmax 3 HOUR
PPB 50 PERCENT
t1/2 12 HOUR

MW 176.17
NB_atoms 13
XLogP 0.60
PSA 64.14
NB_HD 2
NB_HA 4
fsp3 0.11
Lipinski(0=no;1=yes) 1

FDA
NDA 016832 (label) INN (PEMOLINE) CYLERT (ABBOTT) APPROVAL= AP YEAR= 1975 DISCONTINUED
NDA 017703 (label) INN (PEMOLINE) CYLERT (ABBOTT) APPROVAL= AP YEAR= 1976 DISCONTINUED
NDA 075030 (pdf not found) INN (PEMOLINE) PEMOLINE (TEVA PHARMS) APPROVAL= AP YEAR= 1999 DISCONTINUED
NDA 075286 (pdf not found) INN (PEMOLINE) PEMOLINE (FOSUN PHARMA) APPROVAL= AP YEAR= 1999 DISCONTINUED
NDA 075287 (pdf not found) INN (PEMOLINE) PEMOLINE (WATSON LABS) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 075328 (pdf not found) INN (PEMOLINE) PEMOLINE (VINTAGE PHARMS) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 075555 (pdf not found) INN (PEMOLINE) PEMOLINE (TEVA PHARMS) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 075595 (pdf not found) INN (PEMOLINE) PEMOLINE (ACTAVIS ELIZABETH) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 075678 (pdf not found) INN (PEMOLINE) PEMOLINE (ACTAVIS ELIZABETH) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 075726 (pdf not found) INN (PEMOLINE) PEMOLINE (MALLINCKRODT) APPROVAL= AP YEAR= 2001 DISCONTINUED